Eriksen EF - Search Results

1

Estrogen supplementation modulates effects of the endocrine disrupting pollutant PCB126 in rat bone and uterus: diverging effects in ovariectomized and intact animals.

Lind PM, Eriksen EF, Lind L, Orberg J, Sahlin L. Lind PM, et al. Among authors: eriksen ef. Toxicology. 2004 Jul 1;199(2-3):129-36. doi: 10.1016/j.tox.2004.02.022. Toxicology. 2004. PMID: 15147787

2

Effects of the antiestrogenic environmental pollutant 3,3',4,4', 5-pentachlorobiphenyl (PCB #126) in rat bone and uterus: diverging effects in ovariectomized and intact animals.

Lind PM, Eriksen EF, Sahlin L, Edlund M, Orberg J. Lind PM, et al. Among authors: eriksen ef. Toxicol Appl Pharmacol. 1999 Feb 1;154(3):236-44. doi: 10.1006/taap.1998.8568. Toxicol Appl Pharmacol. 1999. PMID: 9931283

3

Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men.

Johansson AG, Eriksen EF, Lindh E, Langdahl B, Blum WF, Lindahl A, Ljunggren O, Ljunghall S. Johansson AG, et al. Among authors: eriksen ef. J Clin Endocrinol Metab. 1997 Sep;82(9):2795-8. doi: 10.1210/jcem.82.9.4148. J Clin Endocrinol Metab. 1997. PMID: 9284698

4

Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial.

Eastell R, Lang T, Boonen S, Cummings S, Delmas PD, Cauley JA, Horowitz Z, Kerzberg E, Bianchi G, Kendler D, Leung P, Man Z, Mesenbrink P, Eriksen EF, Black DM; HORIZON Pivotal Fracture Trial. Eastell R, et al. Among authors: eriksen ef. Osteoporos Int. 2010 Jul;21(7):1277-85. doi: 10.1007/s00198-009-1077-9. Epub 2009 Oct 3. Osteoporos Int. 2010. PMID: 19802508 Free PMC article. Clinical Trial.

5

No evidence for reduced spontaneous or growth-hormone-stimulated serum levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis.

Kassem M, Brixen K, Blum W, Mosekilde L, Eriksen EF. Kassem M, et al. Among authors: eriksen ef. Eur J Endocrinol. 1994 Aug;131(2):150-5. doi: 10.1530/eje.0.1310150. Eur J Endocrinol. 1994. PMID: 7521246

6

Growth hormone, insulin-like growth factors and bone remodelling.

Eriksen EF, Kassem M, Langdahl B. Eriksen EF, et al. Eur J Clin Invest. 1996 Jul;26(7):525-34. doi: 10.1046/j.1365-2362.1996.00292.x. Eur J Clin Invest. 1996. PMID: 8864413 Review. No abstract available.

7

The pathogenesis of osteoporosis.

Eriksen EF, Langdahl BL. Eriksen EF, et al. Horm Res. 1997;48 Suppl 5:78-82. doi: 10.1159/000191333. Horm Res. 1997. PMID: 9434049 Review.

8

The influence of thyroid hormones on bone turnover in health and osteopetrosis.

Langdahl BL, Eriksen EF. Langdahl BL, et al. Among authors: eriksen ef. Eur J Endocrinol. 1998 Jul;139(1):10-1. doi: 10.1530/eje.0.1390010. Eur J Endocrinol. 1998. PMID: 9703369 No abstract available.

9

Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.

Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF. Kassem M, et al. Among authors: eriksen ef. J Bone Miner Res. 1994 Sep;9(9):1365-70. doi: 10.1002/jbmr.5650090907. J Bone Miner Res. 1994. PMID: 7817819 Free article. Clinical Trial.

10

Bone changes in metabolic bone disease.

Eriksen EF, Langdahl B. Eriksen EF, et al. Acta Orthop Scand Suppl. 1995 Oct;266:195-201. Acta Orthop Scand Suppl. 1995. PMID: 8553852 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

277 results

Search Page